In:
Journal of Medicine and Palliative Care, Journal of Medicine and Palliative Care, Vol. 3, No. 4 ( 2022-12-26), p. 311-316
Abstract:
Objective: We know that the risk of contracting COVID-19 infection increases due to the immunosuppression of cancer patients in the pandemic and the mortality rates due to infection are higher than the general population. In our study, it was aimed to observe the effects of the pandemic in patients who received radiotherapy for breast cancer, and to analyze the factors affecting their severe COVID-19 infection. Materials and Method: In this study122 patients who were treated and followed up between 01/05/2019-31/12/21 were evaluated during their outpatient clinic controls with a 20-question form created by us after taking their consent. Results: The median age was 50 (range 25-84), and 62 (50.8%) patients had COVID-19 disease. Fatigue was observed in all patients. 86% of the patients had been vaccinated. 63.1% of them were using masks for precaution. The rate of vitamin use was 21.3%. None of the patients with severe disease used vitamins (p:0.61). Vitamin use was less in early-stage patients than in advanced-stage patients (p:0.005). Age, performance, stage, having the disease before or after treatment, time of vaccination were not found statistically significant on severe disease. Conclusion: It has been seen that vaccination, mask and distance are the most effective methods in the prevention of COVID-19 infection in the radiotherapy process of oncology patients. A larger number of patients is needed to evaluate the effect of vitamin use and the type of vitamin used on the severity of COVID-19 infection.
Type of Medium:
Online Resource
ISSN:
2717-7505
DOI:
10.47582/jompac.1175938
Language:
Unknown
Publisher:
Journal of Medicine and Palliative Care
Publication Date:
2022
